Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Alonso

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2020
Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infectionLaura Prieto-Pérez, José Fortes, Carlos Soto, et al.
Multiple Sclerosis and Related Disorders|June 5, 2021
Research priorities in multiple sclerosis in Latin America: A multi-stakeholder call to action to improve patients care: Research priorities in MS in LATAMJuan I Rojas, Edgar Carnero Contentti, Patricio Abad, et al.
Multiple Sclerosis and Related Disorders|January 17, 2021
What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 28, 2020
Validation of a Histologic Scoring Index for C3 GlomerulopathyFernando Caravaca-Fontán, Hernando Trujillo, Marina Alonso, et al.
Neurological Research|October 2, 2022
Disease activity after discontinuation of disease-modifying therapies in patients with multiple sclerosis in Argentina: data from the nationwide registry RelevarEMZanga Gisela, Portinari Carla, Barber Josefina, et al.
Journal of the Neurological Sciences|May 26, 2024
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registryMaria A Piedrabuena, Jorge Correale, Marcela Fiol, et al.
Multiple Sclerosis and Related Disorders|September 3, 2022
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEMJuan I Rojas, Geraldine G Luetic, Carlos Vrech, et al.
Multiple Sclerosis and Related Disorders|May 26, 2019
The Argentinean multiple sclerosis registry (RelevarEM): Methodological aspects and directionsJuan Ignacio Rojas, Adriana Carrá, Jorge Correale, et al.
Multiple Sclerosis and Related Disorders|March 21, 2021
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAMRicardo Alonso, Berenice Silva, Orlando Garcea, et al.
Journal of Youth and Adolescence|April 9, 2025
Global Profiles of Positive Youth Development: A Person-Oriented Analysis among Emerging Adults Living in 21 CountriesJet Uy Buenconsejo, Laura Ferrer-Wreder, Radosveta Dimitrova, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2020
Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infectionLaura Prieto-Pérez, José Fortes, Carlos Soto, et al.
Multiple Sclerosis and Related Disorders|June 5, 2021
Research priorities in multiple sclerosis in Latin America: A multi-stakeholder call to action to improve patients care: Research priorities in MS in LATAMJuan I Rojas, Edgar Carnero Contentti, Patricio Abad, et al.
Multiple Sclerosis and Related Disorders|January 17, 2021
What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 28, 2020
Validation of a Histologic Scoring Index for C3 GlomerulopathyFernando Caravaca-Fontán, Hernando Trujillo, Marina Alonso, et al.
Neurological Research|October 2, 2022
Disease activity after discontinuation of disease-modifying therapies in patients with multiple sclerosis in Argentina: data from the nationwide registry RelevarEMZanga Gisela, Portinari Carla, Barber Josefina, et al.
Journal of the Neurological Sciences|May 26, 2024
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registryMaria A Piedrabuena, Jorge Correale, Marcela Fiol, et al.
Multiple Sclerosis and Related Disorders|September 3, 2022
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEMJuan I Rojas, Geraldine G Luetic, Carlos Vrech, et al.
Multiple Sclerosis and Related Disorders|May 26, 2019
The Argentinean multiple sclerosis registry (RelevarEM): Methodological aspects and directionsJuan Ignacio Rojas, Adriana Carrá, Jorge Correale, et al.
Multiple Sclerosis and Related Disorders|March 21, 2021
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAMRicardo Alonso, Berenice Silva, Orlando Garcea, et al.
Journal of Youth and Adolescence|April 9, 2025
Global Profiles of Positive Youth Development: A Person-Oriented Analysis among Emerging Adults Living in 21 CountriesJet Uy Buenconsejo, Laura Ferrer-Wreder, Radosveta Dimitrova, et al.
Pageof 9